These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 36516224)
21. Metabolomics Profiling of Visceral Adipose Tissue: Results From MESA and the NEO Study. Neeland IJ; Boone SC; Mook-Kanamori DO; Ayers C; Smit RAJ; Tzoulaki I; Karaman I; Boulange C; Vaidya D; Punjabi N; Allison M; Herrington DM; Jukema JW; Rosendaal FR; Lamb HJ; van Dijk KW; Greenland P; de Mutsert R J Am Heart Assoc; 2019 May; 8(9):e010810. PubMed ID: 31017036 [TBL] [Abstract][Full Text] [Related]
22. Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance. Mathioudaki A; Fanni G; Eriksson JW; Pereira MJ Metabolites; 2024 Jul; 14(8):. PubMed ID: 39195507 [TBL] [Abstract][Full Text] [Related]
23. Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. Drogan D; Dunn WB; Lin W; Buijsse B; Schulze MB; Langenberg C; Brown M; Floegel A; Dietrich S; Rolandsson O; Wedge DC; Goodacre R; Forouhi NG; Sharp SJ; Spranger J; Wareham NJ; Boeing H Clin Chem; 2015 Mar; 61(3):487-97. PubMed ID: 25524438 [TBL] [Abstract][Full Text] [Related]
24. Serum and dietary beta-carotene and alpha-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study. Arnlöv J; Zethelius B; Risérus U; Basu S; Berne C; Vessby B; Alfthan G; Helmersson J; Diabetologia; 2009 Jan; 52(1):97-105. PubMed ID: 18985315 [TBL] [Abstract][Full Text] [Related]
26. Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. Palmer ND; Stevens RD; Antinozzi PA; Anderson A; Bergman RN; Wagenknecht LE; Newgard CB; Bowden DW J Clin Endocrinol Metab; 2015 Mar; 100(3):E463-8. PubMed ID: 25423564 [TBL] [Abstract][Full Text] [Related]
27. Alterations in the metabolism of phospholipids, bile acids and branched-chain amino acids predicts development of type 2 diabetes in black South African women: a prospective cohort study. Zeng Y; Mtintsilana A; Goedecke JH; Micklesfield LK; Olsson T; Chorell E Metabolism; 2019 Jun; 95():57-64. PubMed ID: 30954560 [TBL] [Abstract][Full Text] [Related]
28. Associations between metals and metabolomic profiles related to diabetes among adults in a rural region. Debertin JG; Holzhausen EA; Walker DI; Pacheco BP; James KA; Alderete TL; Corlin L Environ Res; 2024 Feb; 243():117776. PubMed ID: 38043890 [TBL] [Abstract][Full Text] [Related]
29. Identification of pathognomonic purine synthesis biomarkers by metabolomic profiling of adolescents with obesity and type 2 diabetes. Concepcion J; Chen K; Saito R; Gangoiti J; Mendez E; Nikita ME; Barshop BA; Natarajan L; Sharma K; Kim JJ PLoS One; 2020; 15(6):e0234970. PubMed ID: 32589682 [TBL] [Abstract][Full Text] [Related]
30. Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study. Sharma S; Dong Q; Haid M; Adam J; Bizzotto R; Fernandez-Tajes JJ; Jones AG; Tura A; Artati A; Prehn C; Kastenmüller G; Koivula RW; Franks PW; Walker M; Forgie IM; Giordano G; Pavo I; Ruetten H; Dermitzakis M; McCarthy MI; Pedersen O; Schwenk JM; Tsirigos KD; De Masi F; Brunak S; Viñuela A; Mari A; McDonald TJ; Kokkola T; Adamski J; Pearson ER; Grallert H Diabetologia; 2024 Sep; ():. PubMed ID: 39349772 [TBL] [Abstract][Full Text] [Related]
31. Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study. Yang SJ; Kwak SY; Jo G; Song TJ; Shin MJ Sci Rep; 2018 May; 8(1):8207. PubMed ID: 29844477 [TBL] [Abstract][Full Text] [Related]
32. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162 [TBL] [Abstract][Full Text] [Related]
34. Several Metabolite Families Display Inflexibility during Glucose Challenge in Patients with Type 2 Diabetes: An Untargeted Metabolomics Study. Fanni G; Eriksson JW; Pereira MJ Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677056 [TBL] [Abstract][Full Text] [Related]
35. Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes. Kataja-Tuomola M; Sundell JR; Männistö S; Virtanen MJ; Kontto J; Albanes D; Virtamo J Diabetologia; 2008 Jan; 51(1):47-53. PubMed ID: 17994292 [TBL] [Abstract][Full Text] [Related]
36. Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetes. Rios S; García-Gavilán JF; Babio N; Paz-Graniel I; Ruiz-Canela M; Liang L; Clish CB; Toledo E; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Guasch-Ferré M; Santos-Lozano JM; Li J; Razquin C; Martínez-González MÁ; Hu FB; Salas-Salvadó J Cardiovasc Diabetol; 2023 Sep; 22(1):252. PubMed ID: 37716984 [TBL] [Abstract][Full Text] [Related]
37. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Xu T; Brandmaier S; Messias AC; Herder C; Draisma HH; Demirkan A; Yu Z; Ried JS; Haller T; Heier M; Campillos M; Fobo G; Stark R; Holzapfel C; Adam J; Chi S; Rotter M; Panni T; Quante AS; He Y; Prehn C; Roemisch-Margl W; Kastenmüller G; Willemsen G; Pool R; Kasa K; van Dijk KW; Hankemeier T; Meisinger C; Thorand B; Ruepp A; Hrabé de Angelis M; Li Y; Wichmann HE; Stratmann B; Strauch K; Metspalu A; Gieger C; Suhre K; Adamski J; Illig T; Rathmann W; Roden M; Peters A; van Duijn CM; Boomsma DI; Meitinger T; Wang-Sattler R Diabetes Care; 2015 Oct; 38(10):1858-67. PubMed ID: 26251408 [TBL] [Abstract][Full Text] [Related]
38. Altered amino acid metabolism between coronary heart disease patients with and without type 2 diabetes by quantitative Zhang L; Zhang Y; Ma Z; Zhu Y; Chen Z J Pharm Biomed Anal; 2021 Nov; 206():114381. PubMed ID: 34583124 [TBL] [Abstract][Full Text] [Related]
39. Blood Metabolomic Measures Associate With Present and Future Glycemic Control in Type 2 Diabetes. 't Hart LM; Vogelzangs N; Mook-Kanamori DO; Brahimaj A; Nano J; van der Heijden AAWA; Willems van Dijk K; Slieker RC; Steyerberg EW; Ikram MA; Beekman M; Boomsma DI; van Duijn CM; Slagboom PE; Stehouwer CDA; Schalkwijk CG; Arts ICW; Dekker JM; Dehghan A; Muka T; van der Kallen CJH; Nijpels G; van Greevenbroek MMJ J Clin Endocrinol Metab; 2018 Dec; 103(12):4569-4579. PubMed ID: 30113659 [TBL] [Abstract][Full Text] [Related]
40. A prospective study of serum metabolites and glioma risk. Huang J; Weinstein SJ; Kitahara CM; Karoly ED; Sampson JN; Albanes D Oncotarget; 2017 Sep; 8(41):70366-70377. PubMed ID: 29050286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]